Market
Outcome of UCL DMT trial on alcohol misuse by end of 2025?
2
Resolution / Starting Odds
Significant reduction in alcohol intake • 25%
Moderate reduction in alcohol intake • 25%
No significant change in alcohol intake • 25%
Increase in alcohol intake • 25%
Results published by University College London or in a peer-reviewed journal
Story
UCL to Trial Dimethyltryptamine (DMT) on UK Volunteers to Combat Alcohol Misuse
Jan 19, 2025, 12:45 PM
Scientists at University College London (UCL) are set to trial the psychedelic drug dimethyltryptamine (DMT) on UK volunteers in an effort to address alcohol misuse. The study aims to determine whether a single dose of this powerful hallucinogen can assist individuals in reducing their alcohol intake. DMT, known for its use in traditional healing ceremonies, has garnered interest as a potential therapeutic agent in treating substance dependence. This initiative aligns with broader discussions in the European Union regarding the regulation and funding of psychedelic therapies, as various organizations advocate for equitable access to such treatments across member states.
View original story
Similar markets
Neither safe nor effective • 25%
Safe but not effective • 25%
Safe and effective • 25%
Effective but not safe • 25%
NGO-led campaigns • 25%
Government-led campaigns • 25%
No campaigns • 25%
Joint government and NGO campaigns • 25%
No • 50%
Yes • 50%
Negative impact • 25%
No significant impact • 25%
Moderate positive impact • 25%
Significant positive impact • 25%
Opposition to labeling changes • 25%
Support for labeling changes • 25%
Other • 25%
Indifference or no opinion • 25%
Positive results • 33%
Inconclusive results • 34%
Negative results • 33%
Worsening condition • 25%
Significant improvement • 25%
No improvement • 25%
Moderate improvement • 25%
21-30% increase • 25%
More than 30% increase • 25%
11-20% increase • 25%
10% or less increase • 25%
Effective only for PTSD • 25%
Effective for both PTSD and alcohol use disorder • 25%
Not effective for either condition • 25%
Effective only for alcohol use disorder • 25%
